Mermerian A - Search Results

1

KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres.

Bosco N, Goldberg A, Zhao X, Mays JC, Cheng P, Johnson AF, Bianchi JJ, Toscani C, Di Tommaso E, Katsnelson L, Annuar D, Mei S, Faitelson RE, Pesselev IY, Mohamed KS, Mermerian A, Camacho-Hernandez EM, Gionco CA, Manikas J, Tseng YS, Sun Z, Fani S, Keegan S, Lippman SM, Fenyö D, Giunta S, Santaguida S, Davoli T. Bosco N, et al. Among authors: mermerian a. Cell. 2023 Apr 27;186(9):1985-2001.e19. doi: 10.1016/j.cell.2023.03.029. Epub 2023 Apr 18. Cell. 2023. PMID: 37075754 Free PMC article.

2

Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways.

Cheng P, Zhao X, Katsnelson L, Camacho-Hernandez EM, Mermerian A, Mays JC, Lippman SM, Rosales-Alvarez RE, Moya R, Shwetar J, Grun D, Fenyo D, Davoli T. Cheng P, et al. Among authors: mermerian a. Elife. 2022 Sep 21;11:e75227. doi: 10.7554/eLife.75227. Elife. 2022. PMID: 36129397 Free PMC article.

3

Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulator.

Rennie GR, Barden TC, Bernier SG, Carvalho A, Deming R, Germano P, Hudson C, Im GJ, Iyengar RR, Jia L, Jung J, Kim E, Lee TW, Mermerian A, Moore J, Nakai T, Perl NR, Tobin J, Zimmer DP, Renhowe PA. Rennie GR, et al. Among authors: mermerian a. Bioorg Med Chem Lett. 2021 May 15;40:127886. doi: 10.1016/j.bmcl.2021.127886. Epub 2021 Mar 2. Bioorg Med Chem Lett. 2021. PMID: 33662540

4

Biomimetic sulfated glycosaminoglycans maintain differentiation markers of breast epithelial cells and preferentially inhibit proliferation of cancer cells.

Habli Z, Deen NNA, Malaeb W, Mahfouz N, Mermerian A, Talhouk R, Mhanna R. Habli Z, et al. Among authors: mermerian a. Acta Biomater. 2021 Mar 1;122:186-198. doi: 10.1016/j.actbio.2020.12.049. Epub 2021 Jan 11. Acta Biomater. 2021. PMID: 33444795

5

Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeys.

Banijamali AR, Wakefield JD, Mermerian AH, Busby RW. Banijamali AR, et al. Among authors: mermerian ah. Pharmacol Res Perspect. 2014 Oct;2(5):e00059. doi: 10.1002/prp2.59. Epub 2014 Jul 2. Pharmacol Res Perspect. 2014. PMID: 25505606 Free PMC article.

6

Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors.

Mermerian AH, Case A, Stein RL, Cuny GD. Mermerian AH, et al. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3729-32. doi: 10.1016/j.bmcl.2007.04.027. Epub 2007 Apr 10. Bioorg Med Chem Lett. 2007. PMID: 17449248

7

Catalytic enantioselective construction of all-carbon quaternary stereocenters: synthetic and mechanistic studies of the C-acylation of silyl ketene acetals.

Mermerian AH, Fu GC. Mermerian AH, et al. J Am Chem Soc. 2005 Apr 20;127(15):5604-7. doi: 10.1021/ja043832w. J Am Chem Soc. 2005. PMID: 15826199

8

Nucleophile-catalyzed asymmetric acylations of silyl ketene imines: application to the enantioselective synthesis of verapamil.

Mermerian AH, Fu GC. Mermerian AH, et al. Angew Chem Int Ed Engl. 2005 Jan 28;44(6):949-52. doi: 10.1002/anie.200461886. Angew Chem Int Ed Engl. 2005. PMID: 15630710 No abstract available.

9

Catalytic enantioselective synthesis of quaternary stereocenters via intermolecular C-acylation of silyl ketene acetals: dual activation of the electrophile and the nucleophile.

Mermerian AH, Fu GC. Mermerian AH, et al. J Am Chem Soc. 2003 Apr 9;125(14):4050-1. doi: 10.1021/ja028554k. J Am Chem Soc. 2003. PMID: 12670217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page